President Biden’s proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump’s administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Leave a Reply